Our data unambiguously corroborates that the ATF6 activators AA147 and AA263 enhanced the folding and reduced the degradation of the epilepsy-causing variant subunits, leading to their productive trafficking to the Golgi and onward to the plasma membrane. The gene discussed is ATF6; the disease is epilepsy.